(Q37019262)

17 August 2017

1 reference

title

Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review (English)

1 reference

17 August 2017

0 references

Sergiy Konovalov

1

1 reference

17 August 2017

Sunanda Muralee

series ordinal

2

1 reference

17 August 2017

Rajesh R Tampi

series ordinal

3

1 reference

17 August 2017

30 November 2007

1 reference

International Psychogeriatrics

17 August 2017

1 reference

17 August 2017

20

1 reference

17 August 2017

2

1 reference

17 August 2017

293-308

1 reference

Gabapentin and behavioral disorders in severe Alzheimer disease

17 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Gabapentin for behavioral agitation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Placebo-controlled study of divalproex sodium for agitation in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Treatment of psychotic symptoms with lamotrigine in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Psychopathology associated with Alzheimer's disease and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Tolerability and effectiveness of lamotrigine in complex elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Treatment of sexual disinhibition in dementia: case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Gabapentin for treatment of behavioral and psychological symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

A preliminary study of carbamazepine in the treatment of assaultive patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Seizures in elderly patients with dementia: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Effect of divalproex sodium on behavioural and cognitive problems in elderly dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Pharmacological management of behavioural and psychological disturbance in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

The effects of sodium valproate on disturbed behavior in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Gabapentin-induced worsening of neuropsychiatric symptoms in dementia with lewy bodies: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Successful treatment of sexual disinhibition in dementia with carbamazepine -- a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Valproate therapy for agitation in dementia: open-label extension of a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

An open trial of valproate for agitation in geriatric neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Carbamazepine for aggressive agitation in demented patients during nursing care

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Topiramate as add-on treatment for patients with bipolar mania

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

New insights into the clinical management of partial epilepsies.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Major and minor depression in Alzheimer's disease: prevalence and impact

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Managing behavioural and psychological symptoms in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Valproic acid treatment of agitation in dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Valproic Acid for Physically Aggressive Behavior in Geriatric Patients

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

Treatment of dementia-associated agitation with gabapentin

1 reference

https://api.crossref.org/works/10.1017%2FS1041610207006540

7 January 2021

10.1017/S1041610207006540

Identifiers

DOI

0 references

1 reference